Development of a novel TLR8 agonist for cancer immunotherapy.
Wang Y, Yang H, Li H, Zhao S, Zeng Y, Zhang P, Lin X, Sun X, Wang L, Fu G, Gao Y, Wang P, Gao D.
Wang Y, et al. Among authors: zhang p.
Mol Biomed. 2020 Sep 10;1(1):6. doi: 10.1186/s43556-020-00007-y.
Mol Biomed. 2020.
PMID: 35006413
Free PMC article.